Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01.04. | Scandinavian ChemoTech Starts 2025 Strong with Q1 Order Intake Exceeding USD 230,000 | 1 | Cision News | ||
21.03. | Scandinavian ChemoTech Secures New Order and Expands Animal Care Operations Through Global Collaboration in Equine Oncology | 1 | Cision News | ||
04.03. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-End Report January - December 2024 | 88 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) hereby publishes the Year-End Report for 2024.
Fourth-quarter sales reached 2 041 KSEK, which is the best quarter in 2024. Total annual sales amounted to 6 566 KSEK-entirely... ► Artikel lesen | |
30.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months | 130 | GlobeNewswire (Europe) | ChemoTech is pleased to announce the signing of new restructured loan agreements to replace its previous short-term bridge financing. The new agreements include a 2.4 MSEK loan from two external investors... ► Artikel lesen | |
24.01. | Scandinavian ChemoTech AB: Scandinavian ChemTech's Animal Care operations showed positive cashflow for 2024 in separate reporting | 110 | GlobeNewswire (Europe) | Scandinavian ChemoTech is pleased to announce that our Animal Care operations would already be showing a positive cash flow if we reported our business areas separately. This underscores the importance... ► Artikel lesen | |
SCANDINAVIAN CHEMOTECH Aktie jetzt für 0€ handeln | |||||
09.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Implements Management Changes to Reduce Costs and Boost Revenues | 124 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB, in line with the structural changes for the group published on December 30, 2024, has decided to implement measures aimed at achieving financial sustainability. As part of... ► Artikel lesen | |
30.12.24 | Scandinavian ChemoTech AB: Scandinavian ChemoTech Splits Business Units to Boost Cash Flow and will suggest a new name for the group | 157 | GlobeNewswire (Europe) | Since 2021, Scandinavian ChemoTech has operated two distinct business units - Human Care and Animal Care. While Human Care was the group's initial focus, the Board of Directors has made key decisions... ► Artikel lesen | |
29.11.24 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care division is heading for a strong fourth quarter 2024 in terms of sales | 104 | GlobeNewswire (Europe) | Animal Care is on track to close 2024 on a high note, with sales in the fourth quarter already reaching approximately 1,500 KSEK and projected to surpass 6,000 KSEK for the full year. This highlights... ► Artikel lesen | |
03.06.24 | Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Scandinavian ChemoTech AB (Record Id 265011) | 503 | GlobeNewswire | With effect from June 04, 2024, the subscription rights in Scandinavian
ChemoTech AB will be traded on First North Growth Market. Trading will continue
up until and including June 13, 2024.
Instrument:... ► Artikel lesen | |
03.06.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 03.06.2024 | 678 | Xetra Newsboard | Das Instrument 6AH KYG063181021 AUSNUTRIA DAIRY HD-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 03.06.2024 und ex Kapitalmassnahme am 04.06.2024 The instrument 6AH KYG063181021 AUSNUTRIA DAIRY... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PROCEPT BIOROBOTICS | 52,56 | 0,00 % | PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops | ||
BRIGHTSPRING HEALTH SERVICES | 16,550 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 18,040 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance | Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,350 | +1,02 % | EQS-DD: Siemens Healthineers AG: Darleen Caron, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
22.04.2025 / 17:45... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 6,490 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2024 Results | SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
FRESENIUS | 39,860 | +0,03 % | ANALYSE-FLASH: Barclays senkt Ziel für Fresenius SE - 'Overweight' | LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat das Kursziel für Fresenius von 44,00 auf 43,50 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Die Bad Homburger dürften... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 43,000 | +1,30 % | Siemens Energy haussiert, Fresenius Medical Care prallt ab: DAX-Ausblick | Der DAX hat in der vergangenen Woche weiter Boden gutgemacht. Unter dem Strich legte das größte deutsche Börsenbarometer mehr als 800 Punkte zu und schloss +4,08% höher mit 21.205 Punkten. Auf dem Kaufzettel... ► Artikel lesen | |
GERRESHEIMER | 54,15 | +1,03 % | Jetzt oder nie! Gerresheimer-Aktie mit Turnaround und Kursziel 122,50 Euro? | ||
UNITEDHEALTH | 376,65 | +1,02 % | UnitedHealth Group: Einsteigen oder abwarten? | ||
NUTEX HEALTH | 140,51 | 0,00 % | Nutex Health Inc. (NUTX): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout | ||
GENEDX | 109,22 | 0,00 % | GeneDx To Buy Fabric Genomics | ||
CARL ZEISS MEDITEC | 58,30 | -0,77 % | Aktien KW 16 Erholung. Aber: Death Cross als Crash-Menetekel? Oder gibt's Hoffnung? News. Rheinmetall. Kontron. Evotec. Nvidia. Hamborner REIT. MHP Hotels. Forvia Hella. Hensoldt. Circus. Berentzen. Fortec. Carl Zeiss MediTec. Drägerwerk. Agnicio Mining | Aktien Wochenrückblick - die Märkte scheinen sich langsam an die Zitterphase zu gewöhnen. Aktuelle Kurserholung dauerhaft? Oder was kommt noch: Zollankündigung, Handelskrieg mit China, 90 Tage Moratorium... ► Artikel lesen | |
RXSIGHT | 14,730 | 0,00 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
DOCGO | 2,220 | 0,00 % | Pre-market Movers: Interactive Strength, DocGo, DLocal, Iovance Biotherapeutics, Acadia Healthcare | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.00 A.M. ET).In the Green Interactive Strength Inc. (TRNR) is up over 30% at... ► Artikel lesen | |
THERMO FISHER | 378,20 | +0,91 % | Geschäftszahlen veröffentlicht: Thermo Fisher überrascht mit starken Zahlen - Aktie vor Kurssprung? | © Foto: © Copyright 2024 Thermo Fisher ScientificDer US-Wissenschaftsdienstleister Thermo Fisher hat Einblick in seine Geschäftsbücher gegeben.Thermo Fisher Scientific, der weltweit führende Wissenschaftsdienstleister... ► Artikel lesen |